WVE

Wave Life Sciences Ltd

Jun 05 • 04:00PM ET

5.73

-0.36 -5.91 %

Healthcare • Biotechnology • Singapore • Small • NASD

Peers: NTLA BEAM IONS CRSP EDIT ALNY BMRN KRYS RYTM INCY

| Held by: IWM VXF IBB IWO VTWO SCHA XPH DFAS VHT IWC

Index	RUT	P/E	-	EPS (ttm)	-1.05	Insider Own	17.97%	Shs Outstand	192.34M	Perf Week	-12.92%
Market Cap	1.10B	Forward P/E	-	EPS next Y	-1.29	Insider Trans	36.04%	Shs Float	157.83M	Perf Month	-21.40%
Enterprise Value	573.59M	PEG	-	EPS next Q	-0.30	Inst Own	78.46%	Short Float	11.26%	Perf Quarter	-56.33%
Income	-183.59M	P/S	15.35	EPS this Y	8.12%	Inst Trans	-9.80%	Short Ratio	3.75	Perf Half Y	-19.75%
Sales	71.80M	P/B	2.15	EPS next Y	-16.41%	ROA	-42.11%	Short Interest	17.77M	Perf YTD	-66.29%
Book/sh	2.66	P/C	2.02	EPS next 5Y	1.02%	ROE	-53.11%	52W High	21.73 -73.63%	Perf Year	-15.11%
Cash/sh	2.83	P/FCF	-	EPS past 3/5Y	16.10% 20.52%	ROIC	-35.37%	52W Low	5.02 14.14%	Perf 3Y	33.88%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	127.08% 16.31%	Gross Margin	87.47%	Volatility	7.30% 5.65%	Perf 5Y	-15.36%
Dividend TTM	-	EV/Sales	7.99	EPS Y/Y TTM	-27.41%	Oper. Margin	-274.21%	ATR (14)	0.40	Perf 10Y	-63.96%
Dividend Ex-Date	-	Quick Ratio	11.26	Sales Y/Y TTM	-31.58%	Profit Margin	-255.70%	RSI (14)	34.21	Recom	1.06
Dividend Gr. 3/5Y	- -	Current Ratio	11.26	EPS Q/Q	54.82%	SMA20	-10.84%	Beta	-1.32	Target Price	23.83
Payout	-	Debt/Eq	0.03	Sales Q/Q	316.85%	SMA50	-16.62%	Rel Volume	0.83	Prev Close	6.09
Employees	317	LT Debt/Eq	0.01	Earnings	Apr 28 BMO	SMA200	-42.54%	Avg Volume	4.74M	Price	5.73
IPO	Nov 11, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	59.81% 352.57%	Trades		Volume	3,953,291	Change	-5.91%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-29-26	Resumed	Truist	Buy	$15
Feb-05-26	Initiated	BofA Securities	Buy	$38
Dec-12-25	Reiterated	Wedbush	Outperform	$20 → $33
Dec-09-25	Upgrade	RBC Capital Mkts	Sector Perform → Outperform	$27
Oct-20-25	Initiated	Wells Fargo	Overweight	$18
Aug-04-25	Initiated	Canaccord Genuity	Buy	$19
Jul-28-25	Initiated	Oppenheimer	Outperform	$24
Jul-16-25	Initiated	Citigroup	Buy	$16
Jun-11-25	Resumed	Raymond James	Outperform	$14
Apr-29-25	Initiated	Cantor Fitzgerald	Overweight	$10
Apr-08-25	Initiated	Wedbush	Outperform	$18
Feb-25-25	Initiated	Jefferies	Buy	$26
Oct-16-24	Upgrade	Raymond James	Outperform → Strong Buy	$22
Sep-27-24	Resumed	JP Morgan	Overweight	$10 → $13
Sep-19-24	Initiated	B. Riley Securities	Buy	$11
Sep-09-24	Initiated	JP Morgan	Overweight	$10
May-15-24	Initiated	Wells Fargo	Overweight	$11
Dec-19-23	Upgrade	Leerink Partners	Market Perform → Outperform	$5 → $12
Jul-05-23	Initiated	Raymond James	Outperform	$7
May-24-23	Downgrade	Jefferies	Buy → Hold	$7 → $5

Show Previous Ratings

Jun-02-26 08:30AM	Eco Wave Power Featured for Second Time in NVIDIA Founder and CEO Jensen Huang's GTC Keynote, as Company Advances Taiwan Wave Energy Project (PR Newswire) -9.11%
Jun-01-26 08:30AM	Wave Life Sciences to Present at Upcoming Investor Conferences (GlobeNewswire)
May-20-26 06:43AM	Immunovants potential autoimmune blockbuster; Waves RNA editing update (BioPharma Dive)
May-19-26 09:49AM	Wave Life Sciences Supports AlphaDetect to Accelerate Detection of Alpha-1 (PR Newswire)
May-18-26 04:30PM	Wave Life Sciences Announces Positive Update on RestorAATion-2 Trial: WVE-006 (GalNAc-RNA Editing) Achieves MZ-Like Phenotype Across Both Biweekly and Monthly Dosing (GlobeNewswire) -5.47%
04:05PM	Loading…
May-13-26 04:05PM	Wave Life Sciences to Present at 2026 RBC Capital Markets Global Healthcare Conference (GlobeNewswire)
Apr-29-26 08:30AM	Wave Life Sciences Ltd. Q1 2026 Earnings Call Summary (Moby) -6.25%
03:05AM	WAVE Life Sciences Ltd (WVE) Q1 2026 Earnings Call Highlights: Revenue Surge and Strategic ... (GuruFocus.com)
Apr-28-26 07:37AM	Wave Life Sciences: Q1 Earnings Snapshot (Associated Press) +8.36%
07:30AM	Wave Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Update (GlobeNewswire)
Apr-22-26 08:30AM	Wave Life Sciences First Quarter 2026 Financial Results Scheduled for April 28, 2026 (GlobeNewswire)
Apr-21-26 04:01PM	Wave Life Sciences Announces Hearing on Proposed Redomiciliation to the United States (GlobeNewswire)
Apr-15-26 04:01PM	Wave Life Sciences Announces Proposed Redomiciliation to the United States (GlobeNewswire)
Apr-03-26 01:45PM	Gold Royalty, Wave Life Sciences, and More Stocks See Action From Activist Investors (Barrons.com)
Mar-27-26 08:35AM	Waves stock crashes 50% on Phase I obesity data (Clinical Trials Arena)
02:48PM	Loading…
Mar-26-26 02:48PM	Dow dips, Nasdaq falls as oil surges, Trump says Iran 'better get serious' (Proactive) -49.59%
12:30PM	Wave Life Sciences shares plummet on weight loss therapy update (Proactive)
09:40AM	Wave Plunges More Than 50% After Obesity Shot Falls Short (Bloomberg)
09:40AM	Wave Life Sciences Crashes 56% As 'Body Composition' Fat-Loss Drug Underwhelms (Investor's Business Daily)
07:30AM	Wave Life Sciences Announces Positive Interim Phase 1 Data from INLIGHT: Further Improvements in Body Composition, with Clinically Meaningful Reductions in Visceral Fat and Waist Circumference, at Six Months Following Single Dose of WVE-007 (GlobeNewswire)
06:46AM	Wave crashes on obesity drug update; Kodiaks reboot pays dividends (BioPharma Dive)
Mar-05-26 08:30AM	Wave Life Sciences Announces Acceptance of Late-Breaking Oral Presentation on WVE-006 for Alpha-1 Antitrypsin Deficiency at the American Thoracic Society International Conference (GlobeNewswire)
Mar-02-26 07:05AM	Wave Life Sciences Teases Near-Term Obesity and RNA Editing Data as INLIGHT Readouts Near (MarketBeat)
Feb-28-26 01:26PM	Wave Life Sciences Ltd. (WVE): A Bull Case Theory (Insider Monkey)
02:14AM	Wave Life Sciences Ltd. (WVE) Announces Fiscal Q4 and Full-Year 2025 Earnings (Insider Monkey)
Feb-27-26 12:39PM	WAVE Life Sciences Q4 Earnings Call Highlights (MarketBeat) -9.31%
Feb-26-26 04:09PM	WAVE Life Sciences Ltd (WVE) Q4 2025 Earnings Call Highlights: Navigating Revenue Decline with ... (GuruFocus.com) +5.64%
12:15PM	Wave Life Sciences (WVE) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
08:30AM	Wave Life Sciences Ltd. Q4 2025 Earnings Call Summary (Moby)
07:49AM	Wave Life Sciences: Q4 Earnings Snapshot (Associated Press Finance)
07:30AM	Loading…
07:30AM	Wave Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update (GlobeNewswire)
Feb-23-26 08:30AM	Wave Life Sciences to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference (GlobeNewswire)
Feb-22-26 06:15AM	Bank of America Predicts Up to 240% Jump for These 2 Strong Buy Stocks (TipRanks)
Feb-19-26 08:30AM	Wave Life Sciences Fourth Quarter and Full Year 2025 Financial Results Scheduled for February 26, 2026 (GlobeNewswire)
Feb-18-26 07:38PM	Analysts Confirm Bullish Outlook on Wave Life (WVE) Over Obesity Treatment (Insider Monkey)
02:02AM	BofA Highlights WVE-007 as Primary Driver For Wave Life Sciences Ltd. (WVE)'s Growth, Projecting Peak Sales Above $11B (Insider Monkey)
Feb-16-26 12:23PM	Wave Life Sciences (WVE) to Benefit From Optimism Surrounding Alpha-1 Antitrypsin Deficiency Program (Insider Monkey)
Feb-07-26 03:33AM	Wave Life Sciences (WVE) Regains Rights to Potential Rare Genetic Disorder Treatment (Insider Monkey)
Feb-05-26 10:12AM	Microsoft downgraded, Snap upgraded: Wall Street's top analyst calls (The Fly)
Feb-03-26 12:30PM	Wave Life Sciences price target raised to $50 from $47 at Clear Street (TipRanks)
Feb-02-26 02:16PM	Wave Life Sciences Reclaims Rare Disease Drug From GSK, Targets Faster FDA Path (Benzinga)
07:30AM	Wave Life Sciences Announces Plans to Accelerate Regulatory Engagement with Full Control of WVE-006 for Alpha-1 Antitrypsin Deficiency (GlobeNewswire)
03:31AM	GSK walks away from pioneering Wave RNA editing drug (BioPharma Dive)
Jan-12-26 07:30AM	Wave Life Sciences Highlights Strategic Priorities for 2026 at the 44th Annual J.P. Morgan Healthcare Conference: Accelerating Development of WVE-007 (INHBE siRNA) for Obesity and Rapidly Advancing RNA Editing Portfolio (GlobeNewswire)
Jan-06-26 04:28PM	Arrowhead Says Its Gene Silencer Doubled Zepbound's Weight Loss (Investor's Business Daily)
11:26AM	Zepbound Boost Gets a Lift From Arrowhead's Drug. The Question Is Whether Patients Will Pay. (Barrons.com)
07:06AM	Three Genomics Stocks Worth Tracking This Year (Zacks)
Jan-05-26 08:30AM	Wave Life Sciences to Present at 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire) -5.96%
Jan-02-26 10:50AM	Wave Life Sciences (WVE) Emerges as Obesity Treatment Contender, Oppenheimer Boosts Price Target (Insider Monkey) -6.18%
Dec-31-25 11:25AM	Wave Life Sciences' (WVE) RNA Obesity Drug WVE-007 Shows Potential to Match GLP-1 Efficacy Without Muscle Loss (Insider Monkey)
Dec-30-25 11:46PM	H.C. Wainwright Maintains A Buy Rating On Wave Life Sciences Ltd. (WVE) (Insider Monkey)
Dec-22-25 10:18PM	Oppenheimer and Truist Lift Wave Life Sciences Ltd. (WVE) Price Targets After Positive Trial (Insider Monkey) +12.45%
Dec-17-25 09:45AM	Share Offerings Prompt Huge Insider Buying in These 3 Biotechs (24/7 Wall St.)
Dec-14-25 02:40PM	Wave Life (WVE) Shares Nearly Triple on Encouraging Obesity Drug Trial (Insider Monkey)
Dec-11-25 04:28PM	Eli Lilly Puts Obesity Field 'On Notice' With Best-Ever Weight Loss (Investor's Business Daily) -17.20%
10:15AM	WVE Stock Surges More Than 180% in a Week: What Is Driving This Rally? (Zacks)
07:13AM	Eli Lilly's Experimental Obesity Drug Cut Weight By 23.7% (Investor's Business Daily)
Dec-10-25 05:27PM	Golden Cross Alert: 3 Stocks With Major Upside Potential (MarketBeat) -5.07%
Dec-09-25 09:50PM	Wave Life Sciences Prices Upsized $350 Million Public Offering of Ordinary Shares and Pre-Funded Warrants (GlobeNewswire) +15.06%
07:39PM	Why Wave Life Sciences Stock Crushed it Again Today (Motley Fool)
02:24PM	Wave Life Sciences (WVE) Soars to 6-Year High on Obesity Drug Clinical Trial (Insider Monkey)
Dec-08-25 06:50PM	Why Wave Life Sciences Stock Vaulted 146% Higher on Monday (Motley Fool) +147.26%
05:01PM	Biggest Stock Movers Today, Dec. 8: CFLT, UL, & More (Motley Fool)
04:51PM	Wave Life Sciences Ltd. (WVE): A Bull Case Theory (Insider Monkey)
04:09PM	Wave Life Sciences Just Targeted Fat Loss, Specifically. Shares Skyrocketed 115%. (Investor's Business Daily)
04:01PM	Wave Life Sciences Announces Proposed $250 Million Public Offering of Ordinary Shares and Pre-Funded Warrants (GlobeNewswire)
03:44PM	Wave Life skyrockets on obesity drug trial, Strategy buys bitcoin (Yahoo Finance Video)
12:46PM	Obesity Biotechs' Gains Hit Shares of Eli Lilly, Novo Nordisk (Barrons.com)
07:30AM	Wave Life Sciences Announces Positive Interim Data from Phase 1 INLIGHT Trial of WVE-007 (INHBE) for Obesity; Single Dose Resulted in Improvement in Body Composition With Fat Loss Similar to GLP-1 at Three Months Without Muscle Loss (GlobeNewswire)
05:32AM	Dyne to seek Duchenne drug approval; Kymera, Wave and Structure shares soar (BioPharma Dive)
Dec-07-25 04:00PM	Wave Life Sciences to Announce Interim Data from the Phase 1 INLIGHT Trial of WVE-007 (INHBE) for Obesity on Monday, December 8, 2025 (GlobeNewswire)
Nov-16-25 10:13PM	Jefferies Maintains "Buy" Rating on Wave Life Sciences (WVE) Amid Its Improving Competitive Positioning (Insider Monkey)
Nov-13-25 06:00AM	WAVE Life Sciences Ltd (WVE) Q3 2025 Earnings Call Highlights: Promising Clinical Advances and ... (GuruFocus.com)
Nov-10-25 08:45AM	Wave Life Sciences (WVE) Reports Q3 Loss, Misses Revenue Estimates (Zacks) -10.31%
07:43AM	Wave Life Sciences: Q3 Earnings Snapshot (Associated Press Finance)
07:30AM	Wave Life Sciences Reports Third Quarter 2025 Financial Results and Provides Business Update (GlobeNewswire)
Nov-07-25 08:30AM	Wave Life Sciences to Present at Upcoming Investor Conferences (GlobeNewswire)
Nov-06-25 07:00PM	CytomX Therapeutics (CTMX) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
Nov-04-25 08:30PM	Wave Life Sciences to Present Preclinical Data Supporting Therapeutic Potential of WVE-007 for Obesity at ObesityWeek 2025 (GlobeNewswire)
08:30AM	Wave Life Sciences Third Quarter 2025 Financial Results Scheduled for November 10, 2025 (GlobeNewswire)
Oct-30-25 05:53AM	Wave Life Sciences (WVE) Soars 8.8%: Is Further Upside Left in the Stock? (Zacks)
Oct-29-25 10:50PM	Correcting and Replacing Wave Life Sciences Announced Positive Target Engagement Data from INLIGHT Clinical Trial of WVE-007 for Obesity During Annual Research Day (GlobeNewswire) +8.83%
04:15PM	Wave Life Sciences Announced Positive Target Engagement Data from INLIGHT Clinical Trial of WVE-007 for Obesity During Annual Research Day (GlobeNewswire)
03:42PM	Wave Life Sciences stock soars after promising clinical data (Investing.com)
Oct-10-25 09:57AM	Strength Seen in Wave Life Sciences (WVE): Can Its 11.4% Jump Turn into More Strength? (Zacks) -7.20%
Sep-18-25 11:35AM	3 Promising Genomics & Synthetic Biology Stocks in Spotlight in 2025 (Zacks)
08:30AM	Wave Life Sciences Announces Virtual Research Day on October 29th and Participation at Upcoming Investor Conferences (GlobeNewswire)
Sep-05-25 09:30AM	B. Riley aggressive buyer of Wave Life on material disconnect (TipRanks)
Sep-03-25 07:48AM	Wave shares sink on new study results for RNA editing drug (BioPharma Dive) -16.84%
07:30AM	Wave Life Sciences Announces Positive Update from Ongoing RestorAATion-2 Trial of WVE-006 in Alpha-1 Antitrypsin Deficiency (GlobeNewswire)
Aug-29-25 05:09AM	Wave Life Sciences Ltd. (WVE) Gains Momentum With Multiple RNA Wins (Insider Monkey)
Aug-03-25 06:25AM	Oppenheimer Predicts Up to 590% Rally for These 2 Strong Buy Stocks (TipRanks)
Jul-31-25 05:01AM	WAVE Life Sciences Ltd (WVE) Q2 2025 Earnings Call Highlights: Progress in RNA Editing Amid ... (GuruFocus.com)
Jul-30-25 09:00AM	Wave Life Sciences (WVE) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
07:58AM	Wave Life Sciences: Q2 Earnings Snapshot (Associated Press Finance)
07:30AM	Wave Life Sciences Reports Second Quarter 2025 Financial Results and Provides Business Update (GlobeNewswire)
Jul-29-25 09:48AM	WAVE Life Sciences Ltd (WVE) Q2 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Jul-24-25 10:00AM	Illumina (ILMN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Jul-23-25 08:30AM	Wave Life Sciences Second Quarter 2025 Financial Results Scheduled for July 30, 2025 (GlobeNewswire) +7.94%
Jul-15-25 08:59AM	Wave Life Sciences Unveils Promising Preclinical Data for Obesity Treatment WVE-007 at ADA Scientific Sessions (Insider Monkey)

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

MDPaul B. Bolno

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
RA CAPITAL MANAGEMENT, L.P.	Director	Mar 26 '26	Buy	6.08	5,305,782	32,265,431	23,508,791	Mar 30 08:30 PM
RA CAPITAL MANAGEMENT, L.P.	Director	Mar 27 '26	Buy	6.43	2,495,623	16,046,856	26,004,414	Mar 30 08:30 PM
RA CAPITAL MANAGEMENT, L.P.	Director	Mar 30 '26	Buy	6.50	971,091	6,312,092	26,975,505	Mar 30 08:30 PM
Francis Chris	See Remarks	Feb 26 '26	Option Exercise	4.28	33,194	141,920	79,767	Feb 27 09:00 PM
Francis Chris	See Remarks	Feb 26 '26	Sale	15.05	33,194	499,593	61,867	Feb 27 09:00 PM
Moran Kyle	Chief Financial Officer	Feb 09 '26	Sale	13.45	3,588	48,259	134,385	Feb 11 09:03 PM
BOLNO PAUL	President and CEO	Feb 09 '26	Sale	13.45	10,480	140,956	275,520	Feb 11 09:02 PM
Francis Chris	See Remarks	Feb 09 '26	Sale	13.45	1,883	25,326	61,867	Feb 11 09:01 PM
Vargeese Chandra	See Remarks	Feb 09 '26	Sale	13.45	3,228	43,417	408,246	Feb 11 09:00 PM
KYLE MORAN	Officer	Feb 09 '26	Proposed Sale	13.45	3,564	47,936		Feb 09 09:30 PM
Chris Francis	Officer	Feb 09 '26	Proposed Sale	13.45	1,870	25,152		Feb 09 09:29 PM
PAUL BOLNO	Officer	Feb 09 '26	Proposed Sale	13.45	10,411	140,028		Feb 09 09:27 PM
Francis Chris	See Remarks	Jan 02 '26	Option Exercise	3.14	9,375	29,438	34,375	Jan 06 09:30 PM
Francis Chris	See Remarks	Jan 02 '26	Sale	16.03	9,375	150,260	25,000	Jan 06 09:30 PM
GSK plc	10% Owner	Dec 11 '25	Buy	19.00	1,470,000	27,930,000	18,245,691	Dec 15 04:32 PM
Rawcliffe Adrian	Director	Dec 08 '25	Option Exercise	5.97	42,000	250,740	54,700	Dec 10 09:45 PM
Rawcliffe Adrian	Director	Dec 08 '25	Sale	15.00	42,000	630,000	12,700	Dec 10 09:45 PM
Wagner Heidi L	Director	Dec 08 '25	Option Exercise	5.97	14,000	83,580	51,930	Dec 10 09:45 PM
Wagner Heidi L	Director	Dec 08 '25	Sale	13.50	14,000	189,000	44,930	Dec 10 09:45 PM
HENRY CHRISTIAN O	Director	Dec 08 '25	Option Exercise	5.07	87,000	440,790	54,700	Dec 10 09:45 PM
HENRY CHRISTIAN O	Director	Dec 08 '25	Sale	14.65	93,445	1,369,324	12,700	Dec 10 09:45 PM
Tan Aik Na	Director	Dec 08 '25	Option Exercise	4.85	119,230	578,270	70,400	Dec 10 09:45 PM
Tan Aik Na	Director	Dec 08 '25	Sale	13.58	134,218	1,823,158	25,400	Dec 10 09:45 PM
Verdine Gregory L.	Director	Dec 08 '25	Sale	13.47	20,000	269,461	275,217	Dec 10 09:45 PM
Francis Chris	See Remarks	Dec 08 '25	Option Exercise	4.78	441,031	2,107,183	147,349	Dec 10 09:45 PM
Francis Chris	See Remarks	Dec 08 '25	Sale	14.57	441,031	6,427,085	25,000	Dec 10 09:45 PM
Moran Kyle	Chief Financial Officer	Dec 09 '25	Option Exercise	9.51	86,000	818,120	139,218	Dec 10 09:45 PM
Moran Kyle	Chief Financial Officer	Dec 08 '25	Option Exercise	3.43	210,000	721,300	189,218	Dec 10 09:45 PM
Moran Kyle	Chief Financial Officer	Dec 08 '25	Sale	14.77	210,000	3,102,000	89,218	Dec 10 09:45 PM
Moran Kyle	Chief Financial Officer	Dec 09 '25	Sale	20.03	50,036	1,001,979	89,218	Dec 10 09:45 PM
CORRIGAN MARK	Director	Dec 08 '25	Sale	13.48	16,115	217,297	28,815	Dec 10 09:45 PM
KYLE MORAN	Officer	Dec 09 '25	Proposed Sale	18.52	86,000	1,592,720		Dec 09 04:24 PM
Henry Family Trust	Affiliate	Dec 08 '25	Proposed Sale	18.52	93,445	1,730,601		Dec 08 07:08 PM
HEIDI L WAGNER	Director	Dec 08 '25	Proposed Sale	7.49	14,000	104,860		Dec 08 04:39 PM
KYLE MORAN	Officer	Dec 08 '25	Proposed Sale	7.49	210,000	1,572,900		Dec 08 04:37 PM
CHRISTOPHER FRANCIS	Officer	Dec 08 '25	Proposed Sale	7.49	483,602	3,622,179		Dec 08 04:36 PM
GREGORY VERDINE	Director	Dec 08 '25	Proposed Sale	7.49	20,000	149,800		Dec 08 04:35 PM
ADRIAN RAWCLIFFE	Director	Dec 08 '25	Proposed Sale	7.49	42,000	314,580		Dec 08 04:34 PM
MARK CORRIGAN	Director	Dec 08 '25	Proposed Sale	7.49	16,115	120,701		Dec 08 04:34 PM
AIK NA TAN	Director	Dec 08 '25	Proposed Sale	13.58	134,218	1,823,158		Dec 08 04:29 PM
Rawcliffe Adrian	Director	Nov 13 '25	Sale	6.79	16,115	109,421	12,700	Nov 14 09:00 PM
RA CAPITAL MANAGEMENT, L.P.	Director	Nov 13 '25	Buy	6.69	1,000	6,688	18,203,009	Nov 14 06:14 PM
ADRIAN RAWCLIFFE	Director	Nov 13 '25	Proposed Sale	6.96	16,115	112,080		Nov 13 04:25 PM
Verdine Gregory L.	Director	Aug 22 '25	Sale	10.00	10,000	100,000	285,217	Aug 26 09:40 PM
BOLNO PAUL	President and CEO	Aug 22 '25	Sale	10.10	217,351	2,194,810	121,000	Aug 26 09:40 PM
PAUL BOLNO	Director	Aug 22 '25	Proposed Sale	9.76	217,351	2,121,346		Aug 22 04:41 PM
GREGORY VERDINE	Director	Aug 22 '25	Proposed Sale	9.76	25,000	244,000		Aug 22 04:38 PM
Tan Aik Na	Director	Aug 15 '25	Option Exercise	9.13	21,000	191,730	61,388	Aug 19 08:00 PM
Tan Aik Na	Director	Aug 15 '25	Sale	9.25	21,000	194,250	40,388	Aug 19 08:00 PM
AIK NA TAN	Director	Aug 15 '25	Proposed Sale	9.25	21,000	194,250		Aug 15 04:59 PM
HENRY CHRISTIAN O	Director	Aug 13 '25	Sale	8.81	9,670	85,193	29,645	Aug 13 08:00 PM
Christian Henry	Director	Aug 13 '25	Proposed Sale	7.70	9,670	74,459		Aug 13 04:02 PM
TAKANASHI KEN	Director	Aug 05 '25	Sale	8.75	4,872	42,630	5,716,303	Aug 07 08:00 PM
Tan Aik Na	Director	Aug 05 '25	Sale	8.75	1,127	9,861	14,988	Aug 07 08:00 PM
Verdine Gregory L.	Director	Jun 13 '25	Sale	6.95	30,000	208,500	282,517	Jun 13 08:00 PM
GREGORY VERDINE	Director	Jun 13 '25	Proposed Sale	7.20	30,000	216,000		Jun 13 04:44 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

WVE

Wave Life Sciences Ltd

Upgrade your Finviz experience